Ortivus AB (OSTO:ORTI A) EPS (Basic): kr-0.40 (TTM As of Mar. 2026)


OSTO:ORTI A Ortivus AB OSTO:ORTI A
50 GF Score
Price kr1.90
GF Value kr2.51
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ortivus AB EPS (Basic)?

Ortivus AB OSTO:ORTI A -5.00% 50 EPS (Basic) is kr-0.40 as of Mar. 2026. GuruFocus rates OSTO:ORTI A with a GF Score™ of 50/100 and a GF Value™ of kr2.51 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Ortivus AB's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was kr-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.40.

Ortivus AB's EPS (Diluted) for the three months ended in Mar. 2026 was kr-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.40.

Ortivus AB's EPS without NRI for the three months ended in Mar. 2026 was kr-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.40.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ortivus AB's highest 3-Year average EPS without NRI Growth Rate was 40.00% per year. The lowest was -37.50% per year. And the median was 15.60% per year.

Ortivus AB  (OSTO:ORTI A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ortivus AB EPS (Basic) Related Terms

Ortivus AB EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Ortivus AB's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortivus AB EPS (Basic) Chart

Ortivus AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.13 -0.41 -0.56 -0.43

Ortivus AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.15 -0.13 -0.10 -0.02
OSTO:ORTI A
50GF Score
Ortivus AB OSTO:ORTI A
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ortivus AB EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ortivus AB's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-21.876-0)/51.469
=-0.43

Ortivus AB's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.349-0)/88.615
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr-0.40 mean?
Ortivus AB (OSTO:ORTI A) has a EPS (Basic) of kr-0.40 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ortivus AB and its competitors.
Is Ortivus AB's EPS (Basic) too high?
Ortivus AB's current EPS (Basic) is kr-0.40. Overall, Ortivus AB has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ortivus AB's EPS (Basic) compare to ISRG and BDX?
Ortivus AB's EPS (Basic) of kr-0.40 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ortivus AB and its competitors. Ortivus AB's current EPS (Basic) is kr-0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ortivus AB stock overvalued right now?
Based on GuruFocus' analysis, Ortivus AB (OSTO:ORTI A) is currently considered Modestly Undervalued. The stock's GF Value™ is kr2.51, compared to a current price of kr1.90 — trading 24.3% below its estimated fair value. The current EPS (Basic) is kr-0.40. Ortivus AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ortivus AB (OSTO:ORTI A), the current EPS (Basic) is kr-0.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ortivus AB (OSTO:ORTI A) Overvalued in 2026?

Based on GuruFocus' analysis, Ortivus AB stock appears to be undervalued. The current stock price of kr1.90 is trading 24.3% below its estimated GF Value™ of kr2.51. GuruFocus considers Ortivus AB to be Modestly Undervalued.

Key valuation signals for OSTO:ORTI A:

  • EPS (Basic): kr-0.40
  • GF Value™: kr2.51 vs. price of kr1.90 (24.3% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the OSTO:ORTI A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ortivus AB Business Description

Other Exchanges ORTI B:Sweden
Address Svardvagen 19, Danderyd, Stockholm, SWE, 182 33
Ortivus AB is a supplier of mobile solutions for modern emergency medical care. The company has developed an user-friendly solutions that supports diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating its solutions with electronic health records, dispatch systems, and national registries, the company ensures fast and secure information management and more integrated care process. Its product portfolio includes MobiMed ePR, MobiMed Monitor, MobiMed FleetCtrl, MobiMed Life, and others.
50GF Score

Get the complete analysis for OSTO:ORTI A

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.90
Price
kr2.51
GF Value